We are live on ! Find out more
FG

Fairman Group Portfolio holdings

AUM $127M Turnover 8.16%
1-Year Est. Return 6.28%
This Fund
S&P 500
This Quarter Est. Return
+2.35%
1 Year Est. Return
+6.28%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$124M
AUM Growth
+$2.6M
Cap. Flow
+$1.24M
Cap. Flow %
1%
Top 10 Hldgs %
69.52%
Holding
284
New
27
Increased
59
Reduced
25
Closed
10
Avg Time Held
1.5 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
1.4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 59.27%
2 Technology 20.52%
3 Financials 10.78%
4 Healthcare 5.34%
5 Consumer Discretionary 1.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HON icon
201
Honeywell
HON
$65.7B
$4.63K ﹤0.01%
23
– –
2023 Q4
7 quarters
SCHW icon
202
Charles Schwab
SCHW
$162B
$4.39K ﹤0.01%
46
– –
2023 Q4
7 quarters
ROK icon
203
Rockwell Automation
ROK
$46.7B
$4.19K ﹤0.01%
12
– –
2023 Q4
7 quarters
IQV icon
204
IQVIA
IQV
$44.1B
$4.18K ﹤0.01%
22
– –
2023 Q4
7 quarters
TEVA icon
205
Teva Pharmaceutical Industries Limited
TEVA
$48.3B
$4.16K ﹤0.01%
+206
New +$3.62K
2025 Q3
0 quarters
CPB icon
206
Campbell Soup
CPB
$5.98B
$4.01K ﹤0.01%
127
+2
+2% +$65
2024 Q1
6 quarters
ASML icon
207
ASML
ASML
$634B
$3.87K ﹤0.01%
+4
New +$3.14K
2025 Q3
0 quarters
QUAL icon
208
iShares MSCI USA Quality Factor ETF
QUAL
$48.9B
$3.7K ﹤0.01%
19
– –
2023 Q4
7 quarters
NVO icon
209
Novo Nordisk
NVO
$174B
$3.5K ﹤0.01%
+63
New +$3.69K
2025 Q3
0 quarters
CHTR icon
210
Charter Communications
CHTR
$12.4B
$3.3K ﹤0.01%
12
– –
2023 Q4
7 quarters
IWD icon
211
iShares Russell 1000 Value ETF
IWD
$83.7B
$3.26K ﹤0.01%
16
– –
2023 Q4
7 quarters
FIVE icon
212
Five Below
FIVE
$12.2B
$3.09K ﹤0.01%
20
– –
2023 Q4
7 quarters
VTRS icon
213
Viatris
VTRS
$20.8B
$3.01K ﹤0.01%
304
– –
2023 Q4
7 quarters
CRH icon
214
CRH
CRH
$54.4B
$2.88K ﹤0.01%
+24
New +$2.54K
2025 Q3
0 quarters
CSCO icon
215
Cisco
CSCO
$429B
$2.87K ﹤0.01%
42
– –
2023 Q4
7 quarters
RTX icon
216
RTX Corp
RTX
$252B
$2.85K ﹤0.01%
17
– –
2023 Q4
7 quarters
EW icon
217
Edwards Lifesciences
EW
$49.6B
$2.8K ﹤0.01%
36
– –
2023 Q4
7 quarters
SNA icon
218
Snap-on
SNA
$19B
$2.77K ﹤0.01%
8
– –
2023 Q4
7 quarters
PRME icon
219
Prime Medicine
PRME
$626M
$2.77K ﹤0.01%
500
– –
2023 Q4
7 quarters
GIB icon
220
CGI
GIB
$15.4B
$2.76K ﹤0.01%
+31
New +$3K
2025 Q3
0 quarters
CCEP icon
221
Coca-Cola Europacific Partners
CCEP
$48.4B
$2.71K ﹤0.01%
30
– –
2023 Q4
7 quarters
CLS icon
222
Celestica
CLS
$38.7B
$2.71K ﹤0.01%
+11
New +$2.22K
2025 Q3
0 quarters
FIS icon
223
Fidelity National Information Services
FIS
$18.8B
$2.64K ﹤0.01%
40
– –
2023 Q4
7 quarters
ACA icon
224
Arcosa
ACA
$7.22B
$2.44K ﹤0.01%
26
– –
2023 Q4
7 quarters
GE icon
225
GE Aerospace
GE
$321B
$2.41K ﹤0.01%
8
– –
2023 Q4
7 quarters

Similar funds

Fairman Group's Q3 2025 Portfolio in Review

As of Q3 2025, Fairman Group held 284 positions worth $124M, up 2.1% from $122M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Fairman Group's Q3 2025 filing shows 27 new, 59 increased, 25 reduced and 10 closed positions. Its largest new stake was Diamond Hill Large Cap Concentrated ETF: 91,273 shares worth $1.19M. The largest sale was Essent Group, an estimated $1.46M.

By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 54% a quarter earlier, followed by Technology and Financials.

  • Fairman Group's largest Q3 2025 buy was Diamond Hill Large Cap Concentrated ETF: 91,273 shares worth $1.19M.
  • Fairman Group added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $2.18M increase.
  • Fairman Group's biggest Q3 2025 reduction was Essent Group, cutting an estimated $1.46M.
  • Fairman Group fully exited State Street SPDR Portfolio Developed World ex-US ETF in Q3 2025, selling an estimated $75.8K.
  • Fairman Group's ten largest holdings make up 70% of its $124M portfolio in Q3 2025.
  • Fairman Group opened 27 new positions and closed 10 in Q3 2025.
  • Fairman Group's portfolio value rose 2.1% quarter-over-quarter to $124M.

Based on Fairman Group's 13F filing for Q3 2025, filed 31 Oct 2025.